Online citations, reference lists, and bibliographies.
← Back to Search

Enhanced Peptide Delivery And Sustainable Release Of Pleurocidin Using N-Succinyl Chitosan Nanoparticle

G. Bupesh, C. Amutha, S. Vasanth, T. S. Vijayakumar, K. Pandian, V. Balachandar, D. R. Gunasekaran
Published 2017 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Chitosan is a natural polymer that can be modified into chemically different types. In order to imply biomedical applications, the chitosan dissolved in aqueous medium. Therefore, in the present study, functionally substituted chemical groups such as O-carboxymethyl chitosan (CMC), N-succinyl chitosan (NSC), quaternary ammonium chitosan (QAC) and tripoly phosphate chitosan (TPC) were synthesized. The peptide derived from Clarias batrachus was used as a drug that is successfully entrapped with NSC nanoparticles and were characterized by FTIR, AFM, SEM, Zeta sizer, fluorescent imaging and SDS-PAGE. In addition, antimicrobial activity was examined. The results of NSC obtained particle size (~64 nm) with highest solubility and 80% of antimicrobial activity against multidrug resistant pathogen Klebsiella pneumonia. Finally, the release profile indicates that the NSC nanoparticles deliver the peptide with 75% sustainable release and good availability up to 96 h. The current research was the first to report the characterization of peptide with NSC nanoparticles by SDS-PAGE, in which the antimicrobial activity was enhanced up to 80%, the particle sizes were obtained ~64 nm from SEM and AFM, and NSC-peptide exhibited 75% of sustainable release and good availability up to 96 h.
This paper references
10.1515/9783111697888-007
E
Adam S. Opalski (1824)
10.1515/9783111576855-015
J
Seguin Hen (1824)
10.1016/j.colsurfb.2013.08.026
New function of molybdenum trioxide nanoplates: toxicity towards pathogenic bacteria through membrane stress.
K. Krishnamoorthy (2013)
characterization of N-succinyl-chitosan and its selfassembly of Nano spheres
(2006)
10.1016/j.bbrc.2010.03.041
Investigation of archaeosomes as carriers for oral delivery of peptides.
Z. Li (2010)
Chitosan as absorption enhancers for poorly absorbable drugs
N.G.M. Schipper (1996)
Diethylmethyl chitosanas antimicrobial agent: synthesis, characterization ad antibacterial effects
M R Avadi (2004)
Chitosan as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells
N G M Schipper (1996)
10.1023/A:1012160102740
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement
N. G. Schipper (2004)
10.1515/9783111576855-016
K
Martin P. Catherwood (1824)
10.5040/9781474284028.0024
S
A. Kumar (1824)
10.1016/S0169-409X(98)00075-1
Oral insulin delivery.
Carino (1999)
10.1016/S0378-5173(96)04847-8
Evaluation of the biological properties of soluble chitosan and chitosan microspheres
B. Carreño-Gómez (1997)
10.1016/j.arcped.2012.01.013
[Et al].
P. Cochat (2012)
10.1155/2010/898910
Preparation and characterization of water-soluble chitosan nanoparticles as protein delivery system
Hongliang Zhang (2010)
10.1515/9783050077338-026
Y
E. M. S. J. xviii (1824)
10.1016/J.EJPB.2003.09.006
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
A. Vila (2004)
10.1016/J.BBRC.2004.09.007
A protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres.
C. Zheng (2004)
10.1016/S0169-409X(01)00149-1
Exploiting M cells for drug and vaccine delivery.
M. A. Clark (2001)
10.1515/9783111576855-009
D
Saskia Bonjour (1824)
10.1023/A:1018908705446
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
R. Fernández-Urrusuno (2004)
10.1016/S0142-9612(02)00507-0
Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles.
K. Corsi (2003)
10.1016/j.bbrc.2017.10.026
Increased cellular uptake of peptide-modified PEGylated gold nanoparticles.
B. He (2017)
10.1016/S0144-8617(03)00051-1
Chemical characteristics of O-carboxymethyl chitosans related to the preparation conditions
X. Chen (2003)
10.1016/S0378-5173(02)00486-6
Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo.
Yan Pan (2002)
10.1016/0021-9797(89)90299-3
Charge distribution in poly(N,N-l-lysinediylterephthaloyl) microcapsule membranes
Shinji Sakuma (1989)
10.1016/S0168-3659(00)00330-8
A novel bioadhesive intranasal delivery system for inactivated influenza vaccines.
M. Singh (2001)
10.1016/j.bbrc.2017.10.156
Chitosan-coated doxorubicin nano-particles drug delivery system inhibits cell growth of liver cancer via p53/PRC1 pathway.
B. Ye (2018)
10.1016/S0378-5173(98)00378-0
Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA.
S. Richardson (1999)
10.1016/0168-3659(94)00112-8
Zero order release of protein from poly(d,l-lactide-co-glycolide) microparticles prepared using a modified phase separation technique
J. P. Mcgee (1995)
10.1023/A:1026498209874
Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles
M. van de Weert (2004)
10.4172/2157-7439.1000355
Enhanced Antibacterial, Anticancer Activity from Terminalia chebula Medicinal Plant Rapid Extract by Phytosynthesis of Silver Nanoparticles Core-shell Structures
G. Bupesh (2016)
10.1023/A:1018901302450
Chitosan as a Novel Nasal Delivery System for Peptide Drugs
L. Illum (2004)
10.1016/S0142-9612(99)00125-8
Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles.
C. E. Soma (2000)
10.1016/B978-0-12-384931-1.00018-0
R
J. Lackie (2013)
10.1016/S0168-3659(01)00294-2
Chitosan nanoparticles as delivery systems for doxorubicin.
K. Janes (2001)
10.1515/9783111413426-013
L
Il Liceo (1824)
10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers
P. Calvo (1997)
10.1016/J.ADDR.2006.03.001
Natural polymers for gene delivery and tissue engineering.
Jiyoung M Dang (2006)
10.1046/j.1464-5491.2003.01076.x
Alternative routes of insulin delivery
D. Owens (2003)
10.1016/0168-3659(95)00146-8
The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro
G. Borchard (1996)
10.1016/b978-0-12-384931-1.00003-9
C
J. Lackie (2013)
10.1002/APP.12894
Preparation of O-carboxymethyl chitosans and their effect on color yield of acid dyes on silk
Y. G. Wu (2003)
10.1016/j.bbrc.2014.05.049
A novel delivery platform for therapeutic peptides.
S. Park (2014)
10.1023/A:1018967116988
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
P. Artursson (2004)
10.1016/S0140-6736(05)61503-6
T
D. Davies (1998)
10.1007/s11051-016-3663-z
Facile synthesis of mercaptosuccinic acid-capped CdTe/CdS/ZnS core/double shell quantum dots with improved cell viability on different cancer cells and normal cells
S. Parani (2016)
10.1016/S0169-409X(01)00180-6
Chitosan and its derivatives as intestinal absorption enhancers.
M. Thanou (2001)
10.1016/j.nano.2009.04.009
Cellular uptake and transport of gold nanoparticles incorporated in a liposomal carrier.
D. Chithrani (2010)



Semantic Scholar Logo Some data provided by SemanticScholar